Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib

Neutrophil-to-lymphocyte ratio (NLR) is considered a prognostic factor in patients with hepatocellular carcinoma (HCC). Our aim is to investigate the prognostic significance of NLR in patients with HCC treated with sorafenib. RESULTS: Median follow-up time was 7 months. Patients were mostly in the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lué, Alberto, Serrano, Maria Trinidad, Bustamante, Francisco Javier, Iñarrairaegui, Mercedes, Arenas, Juan Ignacio, Testillano, Milagros, Lorente, Sara, Gil, Cristina, de la Torre, Manuel, Gomez, Alexandra, Sangro, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732712/
https://www.ncbi.nlm.nih.gov/pubmed/29262546
http://dx.doi.org/10.18632/oncotarget.21528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732712/
https://www.ncbi.nlm.nih.gov/pubmed/29262546
http://dx.doi.org/10.18632/oncotarget.21528

Ejemplares similares